News & Perspective

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Nov 13, 2017

Nov 13, 2017

News Scan for Nov 13, 2017

New MERS cases
Yellow fever in Nigeria
HHS secretary nomination
Legionnaires' at Disney
Canadian flu cost estimate

Sep 15, 2017

Sep 15, 2017

ASP Scan (Weekly) for Sep 15, 2017

Promising novel assay
Transmissible Enterobacteriaceae
Additional FMT benefits
Antibiotic use and VRE infections
European AMR initiative
Antibiotic-resistant brucellosis
Drug-resistant gonorrhea Rx
ESBL bacteria in street kids
Funding for new C diff drug
Antimicrobial resistance in Africa
Antibiotics for asthmatic children
Drug resistance in the ICU

Nov 29, 2016

Nov 29, 2016

News Scan for Nov 29, 2016

Trump unveils HHS pick
Ebola lab worker healthy

Oct 07, 2016

Oct 07, 2016

ASP News Scan for Oct 07, 2016

High-dose colistin treatment
Microbiome stewardship research
BARDA funds rapid diagnostic test
Resistant Shigella
AMR and poverty
MRSA in UK pork
Online antibiotic Rx

Apr 28, 2016

Apr 28, 2016
Zika sample

HHS supports blood sampling to foster new Zika tests

Case numbers increased in US territories, as did travel-linked ones on the mainland, and little changed last week at the global level.

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Nov 15, 2012

Nov 15, 2012

FDA panel endorses H5N1 vaccine with adjuvant

(CIDRAP News) – A government advisory committee yesterday endorsed the safety and immunogenicity of an adjuvant-containing H5N1 influenza vaccine proposed for inclusion in the US pandemic emergency stockpile, signaling that it could become the first adjuvanted flu vaccine to win approval in the United States.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»